NananoMedica develops nanotechnology for biomedical applications. In close collaboration with Wake Forest University, NanoMedica is developing a technology known as âNext-Gen Lab-on-Beadâ - a drug-discovery tool that uses the latest next-generation genetic sequencing technologies. Incorporating the advantages of nanotechnology in molecular discovery allows the identification of new drug candidates and diagnostic reagents to be faster and more efficient. The âlab-on-beadâ refers to a small, one square inch chip similar to a computer chip. In the center, millions of wells are populated by microscopic beads. The researchers then attach potential drug molecules to these beads, allowing them to âprobe millions of drug compounds in one fell swoop. â Scientists are able to take a protein marker for which they want to find a potential treatment and use the lab-on-bead technology to test millions of possibilities at once eliminating the trial and error process that used to take extensive time t
